Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125255272 | 12525527 | 2 | F | 20160823 | 20160704 | 20160830 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-050960 | BRISTOL MYERS SQUIBB | 59.00 | YR | F | Y | 0.00000 | 20160830 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125255272 | 12525527 | 1 | PS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 125 MG, QWK | N | U | 125118 | 125 | MG | SOLUTION FOR INJECTION | /wk | ||||
| 125255272 | 12525527 | 2 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | N | U | 125118 | SOLUTION FOR INJECTION | |||||||
| 125255272 | 12525527 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 125255272 | 12525527 | 4 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | U | 0 | ||||||||||
| 125255272 | 12525527 | 5 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | 2 DF, BID | U | 0 | 2 | DF | BID | ||||||
| 125255272 | 12525527 | 6 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | |||||
| 125255272 | 12525527 | 7 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 125255272 | 12525527 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 10 MG, Q2WK | U | 0 | 10 | MG | TABLET | QOW | |||||
| 125255272 | 12525527 | 9 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | Unknown | 2 DF, BID | U | 0 | 2 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125255272 | 12525527 | 1 | Rheumatoid arthritis |
| 125255272 | 12525527 | 3 | Product used for unknown indication |
| 125255272 | 12525527 | 4 | Product used for unknown indication |
| 125255272 | 12525527 | 5 | Product used for unknown indication |
| 125255272 | 12525527 | 6 | Product used for unknown indication |
| 125255272 | 12525527 | 7 | Product used for unknown indication |
| 125255272 | 12525527 | 8 | Product used for unknown indication |
| 125255272 | 12525527 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125255272 | 12525527 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125255272 | 12525527 | Aura | |
| 125255272 | 12525527 | Cough | |
| 125255272 | 12525527 | Generalised tonic-clonic seizure | |
| 125255272 | 12525527 | Malaise | |
| 125255272 | 12525527 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125255272 | 12525527 | 1 | 20160618 | 20160619 | 0 | |
| 125255272 | 12525527 | 2 | 20160619 | 0 |